From CRISPR Therapeutics Switches CEOs As It Approaches First Clinical Study:

Sam Kulkarni 15x10
Sam Kulkarni 15×10

SAmarth sam Kulkarni CEO CRISPR Therapeutics gene editing CRISPR-CAS9